Stocktoria
Fastest-growing Biological Products, (No Diagnostic Substances) stocks
Biological Products, (No Diagnostic Substances) companies with the strongest year-over-year revenue growth (15%+) and a basic financial-health check. · 8 companies · all Biological Products, (No Diagnostic Substances) →
| Ticker | Company | Piotroski F | Altman Z″ | Rev growth |
|---|---|---|---|---|
| CGEN | COMPUGEN LTD | 6/9 | -0.84 | 161.1% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 6/9 | -2.63 | 94.1% |
| HALO | HALOZYME THERAPEUTICS, INC. | 5/9 | 3.02 | 37.6% |
| KRYS | Krystal Biotech, Inc. | 5/9 | 16.61 | 33.9% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 5/9 | 6.21 | 21.4% |
| ADMA | ADMA BIOLOGICS, INC. | 5/9 | 8.8 | 19.6% |
| VCEL | Vericel Corp | 7/9 | 3.1 | 16.5% |
| RGEN | REPLIGEN CORP | 6/9 | 5.48 | 16.4% |
The same screen in other industries
Fastest-growing Crude Petroleum & Natural Gas stocksFastest-growing Fire, Marine & Casualty Insurance stocksFastest-growing Pharmaceutical Preparations stocksFastest-growing Semiconductors & Related Devices stocksFastest-growing Services-Business Services, NEC stocksFastest-growing Services-Computer Processing & Data Preparation stocksFastest-growing Services-Computer Programming, Data Processing, Etc. stocksFastest-growing Services-Prepackaged Software stocksFastest-growing Surgical & Medical Instruments & Apparatus stocks
← all best-of lists · all Biological Products, (No Diagnostic Substances) companies · screener
Computed from SEC filings plus Stocktoria's own quality scores — informational, not investment advice.